Your session is about to expire
← Back to Search
CFTR Modulator Therapy for Cystic Fibrosis (HyPOINT Trial)
HyPOINT Trial Summary
This trial will study if magnetic resonance imaging (MRI) can be used to track the effects of new CFTR modulator therapies, which are expected to provide major health benefits to patients with Cystic Fibrosis.
HyPOINT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHyPOINT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HyPOINT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can follow the study's schedule and requirements.Criterion Summary: You have been diagnosed with cystic fibrosis and meet specific age and diagnostic criteria. You must be clinically stable, with no recent antibiotic use and no changes in chronic medications. If you are taking a specific CFTR modulator therapy, it must be stable for at least 28 days prior to the first visit. You should also be able to cooperate with MRI procedures and meet certain lung function criteria.I am not pregnant or breastfeeding.You cannot have metal implants or be claustrophobic for a standard MRI.
- Group 1: Phase 1
- Group 2: Initiation of CFTR Modulator
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many sites are administering the clinical trial?
"4 sites are currently running this clinical trial, situated in Charlottesville, Toronto, Madison and other locations. To minimize travelling requirements for the patient, it is most beneficial to seek out a clinic located nearby."
Is there eligibility criteria for joining this medical trial?
"This clinical trial seeks 64 individuals between the ages of 6 to 18 who have cystic fibrosis. The applicants must also demonstrate their willingness and capability in following the visit schedule, possess a certain genotype, take specific medications, and meet age requirements depending on which phase they are applying for."
Is there an ongoing process of enlisting participants in this experiment?
"This medical trial, first posted on January 13th 2020 and last updated on August 29th 2022, is not recruiting at present. However, there are 413 other clinical trials that are actively seeking participants."
To what extent are elderly patients being included in this investigation?
"As outlined in this medical trial's inclusion criteria, the age brackets are between six and eighteen years old."
To what extent could initiation of CFTR Modulator be detrimental to an individual's wellbeing?
"The safety of initiation with a CFTR modulator has been assessed and rated highly at 3, as this is already an accepted therapeutic intervention."
Share this study with friends
Copy Link
Messenger